Literature DB >> 2567303

Nasal carriage of Staphylococcus aureus treated with topical mupirocin (pseudomonic acid) in a children's hospital.

U Frank1, W Lenz, E Damrath, I Kappstein, F D Daschner.   

Abstract

2% mupirocin ointment applied intra-nasally for 5 days was assessed for elimination of nasal carriage of Staphylococcus aureus in 31 staff members in a children's hospital. Three volunteers failed to complete the trial because of side effects, i.e. buccal reddening and swelling, and unpleasant taste. During treatment staphylococcal nasal carriage was not found in any case; of the 24 post-treatment nasal swabs taken 4 days after treatment 22 were still negative. Re-colonization with S. aureus of different phage types occurred in the remaining two cases.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2567303     DOI: 10.1016/0195-6701(89)90017-0

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  5 in total

1.  Successful treatment for carriage of methicillin-resistant Staphylococcus aureus and importance of follow-up.

Authors:  F P N Mollema; J A Severin; J L Nouwen; A Ott; H A Verbrugh; M C Vos
Journal:  Antimicrob Agents Chemother       Date:  2010-06-14       Impact factor: 5.191

2.  Interpretive criteria for disk diffusion susceptibility testing of mupirocin, a topical antibiotic.

Authors:  P C Fuchs; R N Jones; A L Barry
Journal:  J Clin Microbiol       Date:  1990-03       Impact factor: 5.948

3.  Sensitivity to mupirocin of staphylococci isolated from colonized or infected patients in Germany.

Authors:  W Witte; I Klare
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-06       Impact factor: 3.267

4.  Comparative study of mupirocin and oral co-trimoxazole plus topical fusidic acid in eradication of nasal carriage of methicillin-resistant Staphylococcus aureus.

Authors:  F Parras; M C Guerrero; E Bouza; M J Blázquez; S Moreno; M C Menarguez; E Cercenado
Journal:  Antimicrob Agents Chemother       Date:  1995-01       Impact factor: 5.191

5.  Exogenous or endogenous reservoirs of nosocomial Pseudomonas aeruginosa and Staphylococcus aureus infections in a surgical intensive care unit.

Authors:  A Kropec; J Huebner; M Riffel; U Bayer; A Benzing; K Geiger; F D Daschner
Journal:  Intensive Care Med       Date:  1993       Impact factor: 17.440

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.